| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |